Search results
Results From The WOW.Com Content Network
The International Classification of Diseases for Oncology ( ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases. This classification is widely used by cancer registries . It is currently in its third revision (ICD-O-3).
The International Classification of Diseases, Clinical Modification (ICD-9-CM) was an adaptation created by the US National Center for Health Statistics (NCHS) and used in assigning diagnostic and procedure codes associated with inpatient, outpatient, and physician office utilization in the United States. The ICD-9-CM is based on the ICD-9 but ...
hepatic coma. [ 3] Hepatic encephalopathy ( HE) is an altered level of consciousness as a result of liver failure. [ 2] Its onset may be gradual or sudden. [ 2] Other symptoms may include movement problems, changes in mood, or changes in personality. [ 2] In the advanced stages it can result in a coma.
Appearance. Inborn errors of metabolism form a large class of genetic diseases involving congenital disorders of enzyme activities. [ 1 ] The majority are due to defects of single genes that code for enzymes that facilitate conversion of various substances ( substrates) into others ( products ). In most of the disorders, problems arise due to ...
Immunosuppression is a reduction of the activation or efficacy of the immune system. Some portions of the immune system itself have immunosuppressive effects on other parts of the immune system, and immunosuppression may occur as an adverse reaction to treatment of other conditions. [ 1][ 2] In general, deliberately induced immunosuppression is ...
Frequency. >50% of people with cirrhosis [ 4] Ascites ( / əˈsaɪtiz /; [ 5] Greek: ἀσκός, romanized : askos, meaning "bag" or "sac" [ 6]) is the abnormal build-up of fluid in the abdomen. [ 1] Technically, it is more than 25 ml of fluid in the peritoneal cavity, although volumes greater than one liter may occur. [ 4]
The more aggressive forms of disease require treatment with chemotherapy, radiotherapy, immunotherapy and—in some cases—a bone marrow transplant. The use of rituximab has been established for the treatment of B-cell–derived hematologic malignancies, including follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). [7]
Autoimmune Pancreatitis (AIP) is an increasingly recognized type of chronic pancreatitis that can be difficult to distinguish from pancreatic carcinoma but which responds to treatment with corticosteroids, particularly prednisone. [1] Although autoimmune pancreatitis is quite rare, it constitutes an important clinical problem for both patients ...